More about
Acute Thrombotic Thrombocytopenic Purpura
News
May 02, 2024
2 min read
Save
Enzyme replacement therapy curbs bleeding events in congenital blood clotting disorder
Among patients with congenital thrombotic thrombocytopenic purpura, prophylactic therapy with recombinant ADAMTS13 restored normal levels of the enzyme, according to results of a randomized phase 3 study.